Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$775,754
+$46,917 QoQ
Shares Held
6,037
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#2,320
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. MRK ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
This page
|
6,037 | $775,754 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $775,754 | 6,037 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $728,837 | 6,059 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $501,248 | 4,762 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $412,515 | 4,915 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $434,192 | 5,485 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $422,320 | 4,705 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $418,313 | 4,205 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $591,079 | 5,205 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $644,379 | 5,205 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $705,800 | 5,349 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $583,147 | 5,349 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $562,209 | 5,461 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $639,952 | 5,546 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $590,038 | 5,546 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $602,569 | 5,431 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $449,115 | 5,215 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $475,451 | 5,215 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $416,978 | 5,082 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $389,484 | 5,082 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $380,807 | 5,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $390,405 | 5,020 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $355,385 | 4,610 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $458,325 | 5,603 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $468,916 | 5,653 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $437,146 | 5,653 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $699,845 | 9,096 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||